The world's premier event in malignant and non-malignant hematology. The meeting provides an invaluable educational experience and an opportunity to review thousands of scientific abstracts highlighting updates in the hottest topics in hematology. A global community of more than 20,000 hematology professionals from every sub-specialty are in attendance. Adaptive will once again have a large presence this year as we look to highlight more than 16 oral and poster presentations that will feature our immunosequencing technology in research and drug discovery. Come visit the Adaptive booth, #2843.
MEET US IN PERSON
Join us at the 3rd annual Immuno-Oncology 360° in NYC. The program provides a unique 360-degree approach addressing the most-up-to-date information regarding business aspects, clinical advancements and scientific data that will help accelerate clinical trials and FDA approval, ultimately transforming the way cancer is treated.
Formerly known as the ASM Biodefense and Emerging Infectious Diseases Research Meeting, the 2017 ASM Biothreats: Research, Response, and Policy meeting will discuss a wide-range of biological threats and emerging infectious diseases to stimulate knowledge-sharing amongst stakeholders in academia, industry and government; and to help the overlapping communities prepare for, mitigate, and prevent these global threats.
Novel biotherapies, specific kinase inhibitors and immunomodulatory antibodies have revolutionized the treatment of cancer, autoimmunity, and infectious diseases. This new era of molecular medicine has become possible thanks to major advances in immunology. The focus of this International Symposium on Immune Responses in Cancer and Infection is therefore to highlight recent progress in immunology, from the early steps of the immune response to the late regulation of inflammation and T and B cell responses in the settings of infection and cancer.
The ICI 2017: 19th International Conference on Immunology aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Immunology. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Immunology.
Attracting over 3,500 drug discovery and development professionals from over 40 countries in 2016, the Tri-Conference has grown into a diverse event, focusing on Molecular Medicine, specifically on Discovery, Genomics, Diagnostics and Information Technology.
The BMT Tandem Meetings are the combined annual meetings of the Center for International Blood & Marrow Transplant Research (CIBMTR) and the American Society for Blood and Marrow Transplantation (ASBMT). Investigators, clinicians, laboratory technicians, clinical research professionals, nurses, pharmacists, administrators, and allied health professional attendees benefit from the full scientific program that addresses the most timely issues in hematopoietic cell transplantation.
The ASCO-SITC Clinical Immuno-Oncology Symposium is a three-day meeting focused on clinical and translational research in immuno-oncology and the implications for clinical care. This is a new meeting, one that will address the high-level of need for clinical education in a field where all aspects of care are fundamentally different from traditional therapies.